Ministry of Health [Czech Republic]
This sponsor has funded 2 studies across 1 countries.
| EU PAS ID | Status | Title | Protocol uploaded | Results uploaded |
|---|---|---|---|---|
| 23714 | Planned | Renal replacement therapy: The influence of citrate vs. acetate buffering component on indoxyl sulfate elimination during bicarbonate dialysis | No | No |
| 38918 | Ongoing | Is it useful to monitor thiopurine metabolites in pediatric patients with Crohn’s disease on combination therapy? A multicenter prospective... | Yes | No |
PAS by Risk Management Plan (RMP) requirement
Ministry of Health [Czech Republic]
The RMP for a medical product outlines strategies to identify, assess, and mitigate risks, including PAS for further evaluation.
Category 1 studies are imposed as condition of marketing authorisation.
Category 2 studies are imposed as specific obligation of marketing authorisation.
Category 3 studies are required under other circumstances.
PAS by study status
Ministry of Health [Czech Republic]
The study status is defined according to the timeline dates specified.
Planned studies have not collected any data yet.
Ongoing studies collect data and should publish protocols as soon as possible.
Finalised studies should publish results in the first two weeks after finalisation.
Countries
Ministry of Health [Czech Republic]
1 Study countries specified are the following:
- Czechia